hCLiPs EVs Liver Fibrosis Therapy Japan | AcademicJobs
Japanese researchers at Keio University and collaborators reveal hCLiPs-derived extracellular vesicles as a promising cell-free therapy for liver fibrosis, improving scarring in preclinical models and advancing regenerative medicine.
research-publication-newsregenerative-medicineextracellular-vesicles
